news aktuell GmbH

Stories for society: New8 unveils first-year lineup of drama series

Share

European drama collaboration announces wide range of top drama at Content London

Today at Content London, partners within the New8 drama collaboration showcased their first set of eight drama series. New8 brings together eight public service broadcasters from North-Western Europe: ZDF (Germany), NPO (The Netherlands), VRT (Belgium), SVT (Sweden), DR (Denmark), YLE (Finland), RÚV (Iceland) and NRK (Norway) joined forces to create top drama, built on public service values. The first series will be broadcast in the participating countries starting 2025.

The New8 series entertain and shed light on European societies. The first-year slate has a wide span; ranging from heart touching stories on relevant themes – dealing with ethical dilemmas in our commercially driven world – to series playing with European arts and culture, and high-end dramas on events that have changed the world as we see it.  

"We are proud to present this wide range of high-end dramas, a varied bouquet of stories that we strongly believe will become important and appreciated by European audiences", says Hans-Jørgen Osnes, Head of International Financing Drama at NRK.  

The eight titles  

About New8 

The European drama collaboration New8 brings together eight public service broadcasters to co-produce and distribute high-quality drama series. Its aim is to strengthen their offer to local audiences, building on a shared public mission, and create a bigger impact in the international media sector. The collaboration is trust-based: each broadcaster decides which series they bring in. Through New8, partners can build on each other’s knowledge and experience to bring top drama to a wide audience. The New8 drama collaboration was unveiled at MIA, Mercato Internazionale Audiovisivo, in Rome last month.

Full Version: Stories for society: New8 unveils first-year lineup of drama series

Contacts

Contact: ZDF (Zweites Deutsches Fernsehen)
ZDF German Television, 55100 Mainz, Germany
E-Mai: pressedesk@zdf.de

Images

About news aktuell GmbH

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Additional partnership in medical technology: Bosch and R-Biopharm to strengthen Vivalytic analysis platform Plans to use innovative Bosch BioMEMS technology in PCR tests for multiresistant bacteria18.4.2024 10:15:00 CEST | Press release

Bosch and R-Biopharm are jointly investing 150 million euros in the development of new PCR tests and in marketing. PCR test for multiresistant gram-negative (MRGN) bacteria to be developed using novel BioMEMS technology. BioMEMS chips permit simultaneous testing of up to 250 genetic characteristics – in some cases, in less than 15 minutes. Darmstadt, Gerlingen, and Waiblingen, Germany – The market for medical technology is innovative, dynamic, and growing. Bosch sees medical technology as a strategic growth field and intends to expand its Bosch Healthcare Solutions subsidiary, based in Waiblingen. Bosch has now entered into a new partnership with the German diagnostics solutions company R-Biopharm. This partnership will be focused on Bosch’s universal, fully automated Vivalytic molecular diagnostic analysis platform. The two companies will invest a total of 150 million euros by the end of the decade. Within their strategic development and distribution partnership, the partners intend t

Elatec Brings Employee Badge for Apple Wallet to Users17.4.2024 08:45:03 CEST | Press release

Munich, April 17, 2024 – Elatec today announced it is bringing employee badge in Apple Wallet to its customers, enabling an organization’s employees or tenants to unlock access to locations and devices with a simple tap of their iPhone or Apple Watch. Powered by Elatec’s Mobile Credential Manager software, which works hand-in-hand with Elatec’s universal RFID readers, this brings together the world’s most powerful and versatile readers with the best mobile access system available. Employee badge in Apple Wallet helps deliver a convenient and contactless experience for users. Once enabled, employee badge in Apple Wallet allows users to seamlessly and securely add their employee badge to Apple Wallet, and hold their iPhone or Apple Watch near an NFC reader to unlock office doors, turnstiles, elevators and key card-protected amenity spaces — eliminating the need to open an app or present a traditional, plastic access key. With Express Mode, employees do not need to unlock their device to

National Research Center for Applied Cybersecurity ATHENE: Severe Vulnerabilities Discovered in Software to Protect Internet Routing12.4.2024 08:49:14 CEST | Press release

A research team from the National Research Center for Applied Cybersecurity ATHENE led by Prof. Dr. Haya Schulmann has uncovered 18 vulnerabilities in crucial software components of Resource Public Key Infrastructure (RPKI). RPKI is an Internet standard meant to protect Internet traffic from being hijacked by hackers. By now, all affected vendors provided patches for their products. The vulnerabilities could have had devastating consequences: Internet hijacks have already been exploited, e.g., for phishing passwords and other sensitive information, tricking certificate authorities into issuing fraudulent Web certificates, stealing cryptocurrency, distributing malware, and poisoning caches of DNS servers.

Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment10.4.2024 11:00:00 CEST | Press release

The launch in Germany through its step-down subsidiary betapharm marks Dr. Reddy's entry into digital therapeutics in Europe. Nerivio® is the first REN (wearable, FDA-cleared, and CE-marked for acute and/or prevention migraine (with or without aura) treatment for adults and adolescents (≥ 12 years). Nerivio® is worn on the upper arm during treatment and controlled by a smartphone app, making it comfortable and portable. Starting with Germany, followed by Spain and the UK, Dr. Reddy's plans to further increase access to Nerivio® in European countries.

Construction starts at new STIHL production facility in Romania2.4.2024 12:22:37 CEST | Press release

Ground was broken for a new STIHL plant in Oradea, Romania, on March 27, 2024. The new site will be home to a new battery production facility and marks a significant milestone in the growth strategy of the German family business. The international manufacturing network, which features production operations spread across seven countries on four continents, is expanding to include another key location in Europe.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye